FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer
Conclusion
Therapies aimed at FAK degradation may unlock additional therapeutic benefit for the treatment of PDAC through increasing antigen diversity and promoting antigen presentation.
Source: Gut - Category: Gastroenterology Authors: Canel, M., Sławinska, A. D., Lonergan, D. W., Kallor, A. A., Upstill-Goddard, R., Davidson, C., von Kriegsheim, A., Biankin, A. V., Byron, A., Alfaro, J., Serrels, A. Tags: Open access, Gut Pancreas Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Gastroenterology | Immunotherapy | Pancreas | Pancreatic Cancer